companydata.dkBiomedica-Anpartsselskab: Financial statements 2025
CVR: 15234474
Biomedica-Anpartsselskab (CVR 15234474) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK -28,050 compared with DKK 307,277 the year before. Equity amounted to DKK 2,702,360. The solvency ratio was 99.6%.
- Gross Profit
- 0 kr.
- Profit/Loss
- -28,050 kr.
- Equity
- 2,702,360 kr.
- Total Assets
- 2,712,143 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 0 | -28 t. | 2.7 mio. | - |
| 2024 | - | 395 t. | 307 t. | 2.7 mio. | 1 |
| 2023 | - | 755 t. | 589 t. | 2.4 mio. | 0 |
| 2022 | - | 640 t. | 498 t. | 1.8 mio. | - |
| 2021 | - | 512 t. | 402 t. | 1.3 mio. | - |
Find more companies like Biomedica-Anpartsselskab
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2025
Biomedica-Anpartsselskab has published its annual report for 2024. Gross profit came to DKK 395,337, and the net result was DKK 307,277.
About Biomedica-Anpartsselskab
Biomedica-Anpartsselskab is a Danish company of the type Anpartsselskab based in Frederiksberg C, founded in 1991. The company is registered under the industry Vikarbureauers aktiviteter og anden personaleformidling. The management consists of Lars Anders Baumbach. The company is owned by Lars Anders Baumbach. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK -28,050 compared with DKK 307,277 the year before. Equity amounted to DKK 2,702,360.